應用示例 1. 曾揚，吳小紅，胡靚雅，等. 重組8 型腺相關病毒介導HBV急性感染樹鼩模型建立[J].中國實驗動物學報，2013,21（3）：36-41. 2. 王國婧，王剛，董小巖，等.用重組8型腺相關病毒載體介導的乙型肝炎病毒持續感染小鼠模型評價核苷類似物的抗病毒效果[J].生物工程學報，2013,29（1）：95-106. 3.Dan Yang, Longchao Liu, Danming Zhu, etal. A mouse model for HBV immunotolerance and immunotherapy[J]. Cellular & Molecular Immunology. 2013, 1-8.
請在“產品與服務 -> 訂單管理”里拷貝訂單信息，填寫好內容后通過電郵發給我們。
正常為現貨，訂單確認后第二天發貨，到貨時長以物流時間為準；如大量訂購，請提前與銷售經理聯系。
參考文獻 1.?? ?董小巖等 , 高嗜肝性 8 型重組腺相關病毒體內轉導法制備乙型肝炎病毒持續感染小鼠模型 . 2010. 病毒學報 , 26(06): 425-431. 2.?? ?郭燕菊等 , 免疫抑制劑地塞米松可明顯延長乙型肝炎病毒抗原在水動力法轉染 HBV 小鼠模型中的表達 . 2010. 病毒學報 ,26(01): 20-26 3.?? ?王剛等，用 rAAV8-1.3HBV 制備兩種品系小鼠乙型肝炎病毒感染模型的比較研究 . 2012. 病毒學報 , 28(05): 541-547 4.?? ?朱欣瑤等 , 比較不同血清型 AAV 攜帶 HBV 基因組建立乙肝小鼠模型效果 . 2012. 生物工程學報 ,28(1):1-9. 5.?? ?王國婧等 , 用重組 8 型腺相關病毒載體介導的乙型肝炎病毒持續感染小鼠模型評價核苷類似物的抗病毒效果 . 2013. 生物工程學報 , 29(01): 95-106. 6.?? ?曾揚等 , 重組8型腺相關病毒介導 HBV 急性感染樹鼩模型建立 . 中國實驗動物學報 , 2013, 21(03): 36-41. 7.?? ?Bian Y, Zhang Z, Sun Z, Zhao J, Zhu D, Wang Y, Fu S, Guo J, Liu L, Su L, Wang FS, Fu YX, Peng H. 2017. Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice. Hepatology 66:1067-1082. 8.?? ?Dion S, Bourgine M, Godon O, Levillayer F, Michel ML. 2013. Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules. Journal of virology 87:5554-5563. 9.?? ?Kong X, Sun R, Chen Y, Wei H, Tian Z. 2014. gammadeltaT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance. J Immunol 193:1645-1653. 10.?? ?Wang Z, Zhu K, Bai W, Jia B, Hu H, Zhou D, Zhang X, Xie Y, Bourgine MM, Michel ML, Lan K, Deng Q. 2014. Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection. Journal of virology 88:3004-3015. 11.?? ?Yang D, Liu L, Zhu D, Peng H, Su L, Fu YX, Zhang L. 2014. A mouse model for HBV immunotolerance and immunotherapy. Cellular & molecular immunology 11:71-78. 12.?? ?Cheng L, Li F, Bility MT, Murphy CM, Su L. 2015. Modeling hepatitis B virus infection, immunopathology and therapy in mice. Antiviral research 121:1-8. 13.?? ?Dai K, Huang L, Chen J, Yang L, Gong Z. 2015. Amphiregulin promotes the immunosuppressive activity of intrahepatic CD4(+) regulatory T cells to impair CD8(+) T-cell immunity against hepatitis B virus infection. Immunology 144:506-517. 14.?? ?Dai K, Huang L, Sun X, Yang L, Gong Z. 2015. Hepatic CD206-positive macrophages express amphiregulin to promote the immunosuppressive activity of regulatory T cells in HBV infection. Journal of leukocyte biology 98:1071-1080. 15.?? ?Li J, Zong L, Sureau C, Barker L, Wands JR, Tong S. 2016. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor. Journal of virology 90:8302-8313. 16.?? ?Zhu D, Liu L, Yang D, Fu S, Bian Y, Sun Z, He J, Su L, Zhang L, Peng H, Fu YX. 2016. Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination. J Immunol 196:3079-3087. 17.?? ?Zhu W, Xie K, Xu Y, Wang L, Chen K, Zhang L, Fang J. 2016. CRISPR/Cas9 produces anti-hepatitis B virus effect in hepatoma cells and transgenic mouse. Virus research 217:125-132. 18.?? ?楊悅等，中國流行株 C 基因型 HBV 穩定復制表達小鼠模型的建立 . 2016. 解放軍醫學，41(10)：793-797. 19.?? ?Zhao W, Zhou X, Zhao G, Lin Q, Wang X, Yu X, Wang B. 2017. Enrichment of Ly6C(hi) monocytes by multiple GM-CSF injections with HBV vaccine contributes to viral clearance in a HBV mouse model. Human vaccines & immunotherapeutics 13:2872-2882. 20.?? ?Javanbakht H, Mueller H, Walther J, Zhou X, Lopez A, Pattupara T, Blaising J, Pedersen L, Albaek N, Jackerott M, Shi T, Ploix C, Driessen W, Persson R, Ravn J, Young JAT, Ottosen S. 2018. Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo. Molecular therapy. Nucleic acids 11:441-454. 21.?? ?Liu Y, Yao W, Si L, Hou J, Wang J, Xu Z, Li W, Chen J, Li R, Li P, Bo L, Xiao X, Lan J, Xu D. 2018. Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model. Antiviral research 155:39-47. 22.?? ?Tang L, Chen C, Gao X, Zhang W, Yan X, Zhou Y, Guo L, Zheng X, Wang W, Yang F, Liu G, Sun J, Hou J, Li Y. 2018. Interleukin-21 Reinvigorates the Antiviral Activity of Hepatitis B Virus (HBV)-Specific CD8+ T Cells in Chronic HBV Infection. The Journal of infectious diseases. doi: 10.1093/infdis/jiy576.
